Department of Surgery, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonan-cho, Musashino, 180-8610, Tokyo, Japan.
Department of Health Quality Assessment, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Gastric Cancer. 2020 Mar;23(2):310-318. doi: 10.1007/s10120-019-00993-1. Epub 2019 Jul 22.
Laparoscopic gastrectomy (LG) is an established minimally invasive procedure for gastric cancer. However, it is controversial whether LG is useful for patients with poor physical status classified into higher classes of the American Society of Anesthesiologists physical status (ASA-PS) classification. The aim of this study was to determine the feasibility of LG in patients with ASA-PS class ≥ 3.
We extracted data for a total of 28,160 patients with an ASA-PS class ≥ 3 who underwent distal or total gastrectomy for gastric cancer between January 2013 and December 2017 from the National Clinical Database Japan society for gastroenterological surgery registry. We developed a propensity score model from baseline demographics and comorbidities and matched patients undergoing LG to those undergoing open gastrectomy (OG) using a 1:1 ratio. Mortality and morbidities (within 30 days and in-hospital) were compared between the 6998 matched patient pairs.
In-hospital mortality was significantly lower in patients undergoing LG than in those undergoing OG (2.3% vs. 3.0%, p = 0.01), while the 30-day mortality was similar (1.6% vs. 1.5%). The length of hospital stay was significantly shorter in the LG group (median, 14 days vs. 17 days, p < 0.001). The LG group had a significantly lower incidence of postoperative complications in patients with any grade complication (20.3% vs. 22.5%, p = 0.002) as well as those with ≥ grade 3 complications (8.7% vs. 9.8%, p = 0.03).
LG was associated with decreased in-hospital mortality and a lower incidence of several postoperative complications when compared to OG among patients with poor physical condition.
腹腔镜胃切除术(LG)是一种成熟的微创治疗胃癌的方法。然而,对于身体状况较差、美国麻醉医师协会身体状况(ASA-PS)分类较高的患者,LG 是否有用仍存在争议。本研究旨在确定 ASA-PS 分级≥3 的患者行 LG 的可行性。
我们从日本胃肠外科学会注册的全国临床数据库中提取了 2013 年 1 月至 2017 年 12 月期间行远端或全胃切除术治疗胃癌的共 28160 例 ASA-PS 分级≥3 的患者数据。我们根据基线人口统计学和合并症数据建立了倾向评分模型,并采用 1:1 比例将行 LG 的患者与行开腹胃切除术(OG)的患者进行匹配。比较了 6998 对匹配患者的术后 30 天内死亡率和并发症(30 天内和住院内)。
LG 组的住院死亡率显著低于 OG 组(2.3%比 3.0%,p=0.01),而 30 天死亡率相似(1.6%比 1.5%)。LG 组的住院时间明显短于 OG 组(中位数,14 天比 17 天,p<0.001)。LG 组术后任何严重程度并发症的发生率(20.3%比 22.5%,p=0.002)以及≥3 级并发症的发生率(8.7%比 9.8%,p=0.03)均显著低于 OG 组。
与 OG 相比,LG 可降低身体状况较差患者的住院死亡率,并降低几种术后并发症的发生率。